Anorexia nervosa and lipid metabolism disorders
Authors:
Ľubica Tichá; Ľudmila Podracká
Authors place of work:
Detská klinika NÚDCH, Bratislava
Published in the journal:
AtheroRev 2018; 3(3): 173-174
Category:
Reviews
Summary
Although low weight is associated with a low risk of atherosclerotic status, patients with anorexia nervosa have changes in many lipid and hormonal parameters that increase this risk. In literature, secondary dyslipidemia is often described – elevated cholesterol, elevated LDL, but also HDL-cholesterol. Triacylglycerols may be defined as elevated, normal or increased. Despite the unfavorable lipid profile, ischemic heart disease is only a rare cause of prematurely death in patients with anorexia nervosa.
Key words:
anorexia nervosa, lipid metabolism
Received: 10. 9. 2018
Accepted : 2. 10. 2018
Zdroje
- Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association 2013. ISBN 978–0890425558.
- Rigaud D, Tallonneau I, Vergès B. Hypercholesterolemia in anorexia nervosa: frequency and changes during refeeding. Diabetes Metab 2009; 35(1): 57–63. Dostupné z DOI: <http://dx.doi.org/10.1016/j.diabet.2008.08.004>.
- Mordasini R, Klose G, Greten H. Secondary type II hyperlipo-proteinemia in patients with anorexia nervosa. Metabolism 1978; 27: 71–79.
- Arden MR, Weiselberg EC, Nussbaum MP et al. Effect of weight restoration on the dyslipoproteinemia of anorexia nervosa. J Adolesc Health Care 1990; 11(3): 199–202.
- Žák A, Vecka M, Tvrzická E et al. Metabolizmus lipidů u mentální anorexie. Čas Lék Česk 2003, 142(5): 280–284.
- Ohwada R, Hotta M, Oikawa S et al. Ethiology of hyper-cholesterolemia in patients with anorexia nervosa. Int J Eat Disord 2006; 39(7): 598–601. Dostupné z DOI: <http://dx.doi.org/10.1002/eat.20298>.
- Matzkin V, Slobodianik N, Pallaro A et al. Risk factors for cardiovascular disease in patients with anorexia nervosa. Int J Psychiatr Nurs Res 2007; 13(1): 1531–1545.
- Mira M, Stewart PM, Abraham S. Hormonal and biochemical abnormalities in women suffering from eating disorders. Pediatrician 1983–1985; 12(2–3): 148–156.
- Weinbrenner T, Züger M, Jacoby GE et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolemia. Br J Nutr 2004; 91(6): 959–969. Dostupné z DOI: <http://dx.doi.org/10.1079/BJN20041151>.
- Feillet F, Feillet-Coudray C, Bard JM et al. Plasma cholesterol and endogenous cholesterol synthesis during refeeding in anorexia nervosa. Clin Chim Acta 2000; 294(1–2): 45–56.
- Jáuregui-Garrido B, Bolaños-Ríos P, Santiago-Fernández MJ et al. Lipid profile and cardiovascular risk in anorexia nervosa; the effect of nutritional treatment. Nutr Hosp 2012; 27(3): 908–913. Dostupné z DOI: <http://dx.doi.org/10.3305/nh.2012.27.3.5752>.
- Haluzik M, Papezova M, Nedvidkova J et al. Serum leptin levels in patients with anorexia nervosa before and after partial refeeding, relationships to serum lipids and biochemical nutritional parameters. Physiol Res 1999; 48(3): 197–202.
Štítky
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsČlánok vyšiel v časopise
Athero Review
2018 Číslo 3
- Memantine Eases Daily Life for Patients and Caregivers
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- Fibrates in 2018: story goes on
- Statins, brain and cholesterol: is it going together?
- Anorexia nervosa and lipid metabolism disorders
- Lysosomal storage disorders as the cause of dyslipoproteinemia